CEBPA Gene Mutation (Coding Sequence Analysis) [BML]*

฿9,230.00

Analyses the coding sequence of the CEBPA gene for clinically relevant mutations associated with acute myeloid leukaemia.

Blood
15 min at lab
Results: 10 days

Typical Use

Used in people with suspected or confirmed acute myeloid leukaemia to support disease classification and prognostic assessment. It is not a general inherited-cancer screening test.

Preparation

<br>
Wear clothing that allows easy access to your arm
Arrive well-hydrated
Continue regular medications unless advised otherwise by your doctor